NIIMBL and OAGi Release Foundational Ontologies to Advance Data Interoperability in Biopharmaceutical Manufacturing

The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) and the Open Applications Group, Inc. (OAGi) are proud to announc...

November 14, 2025 | Friday | News
New England Biolabs Launches Integrated Indexing Primer Module for Streamlined Influenza A Sequencing on Oxford Nanopore Technologies Platforms

Streamlined, high-throughput sequencing of Influenza A virus with integrated indexing for Oxford Nanopore Technologies® platforms New England Biolab...

November 14, 2025 | Friday | News
Callan JMB Enters Agreement to Host Oral Drug Delivery Manufacturing at Texas cGMP Facility

Callan JMB INC. (NASDAQ: CJMB) (“Callan JMB” or the “Company”), an integrative logistics company empowering the healthcare indust...

November 14, 2025 | Friday | News
Merck CEO Belén Garijo Confirms Confident Momentum Across Healthcare And Life Science

  Net sales increase organically by +5.2% to € 5.3 billion; foreign exchange effects of –4.9%, portfolio effects of +0.7% EBI...

November 14, 2025 | Friday | Company results
AtomVie and Ariceum Achieve First Clinical Dosing of 225Ac-SSO110 in SANTANA-225 Trial

  AtomVie Global Radiopharma (AtomVie), a leading radiopharmaceutical CDMO, announced that it has successfully supplied the first dose of Ariceum The...

November 13, 2025 | Thursday | News
Kytopen and Excellos Partner to Explore Scalable Non-Viral Manufacturing for Next-Generation Cell Therapies

Collaboration will investigate how continuous flow cellular engineering and donor-to-dose manufacturing expertise may advance scalable, non-viral process...

November 13, 2025 | Thursday | News
Pixelgen Technologies and Carolina Molecular Partner to Bring 3D Protein Interactomics to U.S. Researchers

Carolina Molecular Inc., a leading molecular testing services laboratory, and Pixelgen Technologies AB announced  a partnership to expand access to ...

November 13, 2025 | Thursday | News
Atomic Launches to Bridge the Gap Between Breakthrough MedTech Innovation and Venture-Ready Business

-Atomic launches today as a first-of-its-kind service offering for MedTech startups built to bridge the gap between breakthrough concepts and investor-re...

November 13, 2025 | Thursday | News
Daiichi Sankyo Taps General Proximity’s OmniTAC™ Platform to Unlock New Frontiers in Oncology Drug Discovery

The collaboration will leverage General Proximity's OmniTAC™ platform to identify and advance next generation induced proximity agents for...

November 13, 2025 | Thursday | News
Thermo Fisher Secures FDA Clearance for First-of-Its-Kind Automated System to Transform Multiple Myeloma Diagnosis

First-of-its-kind, automated system delivers increased sensitivity, specific identification of disease markers and improved laboratory workflow to suppor...

November 13, 2025 | Thursday | Regulatory
GenomOncology Technology Enables Rapid Launch of Glioblastoma Foundation Genomic Testing Lab

GenomOncology announced a strategic partnership with the Glioblastoma Foundation to transform genomic testing for the nation's most aggressive brain canc...

November 12, 2025 | Wednesday | News
March Biosciences Receives FDA RMAT Designation for MB-105 CAR-T in T-Cell Lymphoma

- March Biosciences (March Bio), a clinical stage biotechnology company developing cell therapies for hard-to-treat cancers,  announced that the U.S...

November 12, 2025 | Wednesday | News
Gnome Sciences Identifies Cancer Drug That Prevented ALS in Preclinical Study

Gnome Sciences, a molecular pathology and translational research services company, announced a significant advance in the fight against ALS (amyotrophic ...

November 12, 2025 | Wednesday | News
Armata Pharmaceuticals Commissions State-of-the-Art cGMP Manufacturing Facility in Los Angeles

Armata Pharmaceuticals, Inc. (NYSE American: ARMP) ("Armata" or the "Company"), a clinical-stage biotechnology company focused on the development of high...

November 11, 2025 | Tuesday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close